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 Corpus luteum is a transient endocrine structure formed from the ruptured ovarian 
follicle. Its main function is to secrete P4, a pro-gestational hormone, essential for 
establishment and maintenance of pregnancy in mammals. The modulators of CL structure 
and function are classified as trophic and lytic factors. The luteotrophic factors include 
pituitary hormones, growth factors, intra luteal factors and cytokines, while luteolytic 
factors include PGF2α and oxytocin. The interplay between luteotrophic and luteolytic 
factors regulates luteal steroidogenesis. The precise timing of expression of various 
enzymes/proteins required for synthesis and metabolism of P4 constitutes an important 
process in the overall regulation of CL function. The three hormones LH/CG, E2 and PRL 
are regarded as luteotrophic factors crucial for control of CL function in mammals. 
Depending on species, either individually or all three hormones in the form of luteotrophic 
complex have been shown to participate in the regulation of CL function. In addition to 
the well-established endocrine role of E2, its secretion is the hallmark of the ovulating 
follicle, has an important role in the intraovarian growth, differentiation and survival of 
cells. 
 Chapter I provides a comprehensive review of literature on CL structure and function 
with emphasis on factors that influence its growth, development, function and demise in 
bovines and rodents. In Chapter II, studies have been carried out to examine 20α-HSD 
expression and its activity in the CL of buffalo cow. During induced and spontaneous 
luteolysis, rapid fall in circulating P4 is one of the early signs of initiation of luteolytic 
process in several species. In rodents, it is well recognized that during luteolysis, P4 is 
catabolized into inactive metabolite, 20α-OHP by the reaction of 20α-HSD enzyme during 
luteolysis. Experiments were carried out to determine 20α-HSD expression and activity 
throughout the luteal phase and during induced luteolysis in the buffalo cow. Circulating 
P4 concentration declined rapidly in response to PGF2α treatment, but HPLC analysis of 
serum samples did not reveal changes in circulating 20α-OHP levels in buffalo cows. In 
contrast, pseudo pregnant rats receiving PGF2α treatment showed higher 20α-OHP levels 
at 24 h post treatment. qPCR expression of 20α-HSD in CL during different stages of 
luteal phase and PGF2α-treated buffalo cows was carried out and higher expression of 20α-
HSD was observed at 3 and 18 h post treatment, but its activity was not altered post PGF2α 
treatment at other time points examined. The expression of the transcription factor Nurr77 
which is involved in increased expression of 20α-HSD increased several fold 3 h post 
PGF2α treatment similar to the observation in PGF2α-treated pseudo pregnant rats. The 
results suggested that the synthesis rather than catabolism of P4 appears to be primarily 




affected by PGF2α treatment in buffalo cows in contrast to increased metabolism of P4 as 
seen in rodents. 
 In bovines, to date no luteotropic actions for E2 has been demonstrated and whether 
E2 has direct effect on CL function has also not been reported. Expression of CYP19A1 
gene that encodes aromatase enzyme although gets down regulated post ovulation but its 
expression recovers in the CL and also E2 biosynthesis has been reported in the bovine 
CL. Recently it was observed that CYP19A1 expression was consistently down regulated 
following administration of luteolytic dose of PGF2α. Experiments were conducted to 
examine the expression of ERα and ERβ in the CL throughout the buffalo estrous cycle as 
well as examined the luteal E2 levels post PGF2α treatment. The results indicated that ER 
expression was detectable during different stages of CL and that circulating and luteal E2 
levels declined post PGF2α treatment. It was hypothesized that decrease in luteal E2 levels 
leads to down regulation of ER signaling and changes in expression of E2 responsive 
genes in the CL. To test the hypothesis, 89 genes which were regarded as E2 responsive 
genes were selected and the previously published global gene expression data of the 
buffalo CL was mined for E2 responsive genes. It was observed that 57 of 89 genes 
regarded as E2 responsive genes were found to be differentially expressed. Since non 
pregnant buffalo CL is not regarded as major site of E2 production, to validate the 
authenticity of differentially E2 expressed genes post PGF2α, CL of another species, the 
macaque, which is known to secrete abundant E2 was included for the analysis. 
Incidentally, the global gene expression data for the PGF2 α treated macaques (in which 
CYP19A1 gene expression also gets down regulated) has previously been reported from 
the laboratory.  Here again, it was observed that nearly 79 of 89 genes were identified to 
be differentially expressed. To further determine the consequences of decreased ER 
signaling, molecules associated with survival and apoptosis were examined. The results 
indicated decreased expression (both mRNA and protein levels) of Akt, Bax and Bcl-2 
genes.  The results suggested an important role for E2 on CL function in the buffalo cow. 
 In Chapter III, several experiments were conducted in another model system, 
pregnant rat, in which aromatase expression and therefore E2 production is high in the CL.  
Experiments were conducted to examine the effects of E2 inhibition and E2 replacement on 
the expression of genes. For this purpose, pregnant rats were treated with a specific 
aromatase inhibitor on day 12-15 of pregnancy. Together with AI, exogenous E2 was 
administered to another group of pregnant rats. The CL collected from different groups of 
rats on day 16 of pregnancy was subjected to microarray analysis. The analysis post 




validation of microarray data has shown that clusters of genes could be segregated into 
various pathways involving luteal steroidogenesis, immune system, various growth factors 
and apoptotic processes, all directed towards the regulation of CL function. The 
involvement of E2 in luteal cell proliferation and lipid deposition well corroborated with 
protein levels for cyclin D1 and ki67 and the results of oil red O staining, respectively. 
There have been reports implicating PI3K/Akt signaling in cyclin D1 accumulation, but 
mechanism of action does not appear to involve transcriptional activation of cyclin D1. 
The results of the present study indicate a decrease in cyclin D1 protein levels due to 
inhibition of PI3K/Akt signaling by AI treatment which is prevented upon administration 
of E2 during AI treatment. The findings provide a comprehensive overview for the 
mechanisms associated with the cell survival, progression, etc. The bioinformatics 
approach provided complete landscape of functional changes affected by the upstream 
regulators of genes associated with survival and apoptosis. Also, the findings further 
strengthen the hypothesis of involvement of E2 in the regulation of CL function by way of 
activation of Akt, the primary mediator of PI3K signaling in the regulation of cellular 
component that affect cell survival.  
In the present study, IGFBP5 which was up regulated during luteal inhibition of E2 
with AI treatment was selected for further studies. Although IGFBP5 is known to be 
associated with follicular atresia in the rat ovary, there is limited data for the involvement 
of IGFBP5 in either a growth stimulatory or inhibitory action on ovarian cells. Based on 
present findings, a causal link between reduced ERα transcriptional activities resulting in 
inhibition of Akt/PKB in the presence of IGFBP5 expression could be proposed. Further, 
the cellular hypertrophy mediated by E2 has been speculated due to increased proliferation 
of vascular endothelial cells, blood supply and thus nutrients. E2, together with PRL and 
placental lactogens, regulates steroidogenesis and cell hypertrophy in the rat CL of 
pregnancy. In CL, the prominent IGFBP5 mRNA expression in different types of luteal 
cells has not been reported. The mRNA expression for IGFBP5 across the two types of 
luteal cells showed higher expression in SLC. Hence, in the present study, it has been 
speculated that prevention of conversion of SLC to LLC due to lack of E2 biosynthesis in 
presence of AI might be acting as a source for the increased IGFBP5 levels during mid 
pregnancy in rat CL and brings about changes associated with lack of E2. 
Various receptor studies on rat CL have demonstrated the lack of progesterone 
receptor (PR) mRNA expression in the rat CL negating its involvement as an 
autocrine/paracrine regulator of CL function through an intracellular receptor, but the 




involvement of non-PR involvement in mediating such mechanism further strengthens the 
role of ERs. The luteotrophic complex formation in pregnant rat principally by PRL and 
E2 has been discussed at length in Chapter III. PRL appears to maintain luteal ER content 
in the CL during rat pregnancy which further determines the luteotrophic and luteolytic 
actions of E2. Further, study on expression of E2 responsive genes would help in 
identifying E2 regulating molecules to get a clear picture on the role of E2 in understanding 
regulation of the CL function. 
 The interaction of E2 with growth factor signaling including the IGF pathway has 
been well established in different species and this interaction is tightly linked to ERα 
expression, an observation interpreted as physiological coupling of growth factor and 
stress signaling pathways. Attempts were made towards understanding cross talk between 
the E2 signaling and the IGF1 signaling in few experiments carried out in Chapter IV. 
Based on the results, it can be proposed that a causal link exists between reduced ERα 
transcriptional activity and inhibition of Akt/PKB in the presence of IGFBP5. The present 
study has shown the activity of IGF on ERα activity mediated partly via PI3K/Akt 
pathway. Hence, the finding further speculates that inhibitory effect of IGFBP5 on E2 
induced ERα function was due to sequestration of IGF1, possibly present in serum or 
produced within the cells. Another striking observation was the down regulation of 
glucocorticoid receptor (GR) gene, NR3C1, in the data of earlier studies [Priyanka, 2009, 
GEO accession number GSE8371 and Kunal, 2014, GEO accession number GSE27961] 
and the present study has been compared and discussed in this thesis. Glucocorticoids 
provide key signals for differentiation of fetal and placental tissues. Therefore, regulation 
of glucocorticoid access to the placenta and fetus is recognized as an important 
determinant of prognosis outcome and subsequent development of the postnatal 
phenotype. Differential regulation of these genes in CL post E2 deprivation and 
replacement further emphasize the regulation of CL via various biological, cellular and 
molecular functions.  
 Interestingly, besides transcriptional regulation of IGF axis components, E2 activated 
ERα also rapidly influence the activity of IGF axis related to signaling proteins in a non-
genomic manner, especially by the PI3K/Akt pathway. PI3K/Akt pathway analysis has 
been carried out in E2 inhibition and replacement experiments. To further confirm the 
observations of E2 and growth factor interaction, experiments have been set up with 
exogenous GH for increasing circulating levels of IGF in the system. The findings suggest 
that the non-genomic signaling pathway activated by the phosphorylation of ERα induced 




by E2 gets inhibited in the presence of AI result in increased expression of IGFBP5. The 
reduction in circulating IGF1 in pregnant rats may be associated with the effect on IGFBP, 
important for determining biological action of IGF1. The changes observed in the present 
study emphasize the exclusive effects of the IGFBP5 on the CL function brought about 
perturbations in luteal E2 content. 
 The experiments described in the present thesis aim at understanding the mechanism 
responsible for decreased serum and luteal P4 post PGF2α treatment in buffalo cows, i.e. 
whether PGF2α acts on biosynthetic or catabolic process of P4. In the present study, 
experiments were designed to elucidate the role of E2 in regulation of CL function, since 
down regulation of CYP19A1 gene mRNA was one of the early events observed in 
buffalo cows post PGF2α treatment. This line of research work was extended to rodents, a 
species that secretes high levels of E2 during pregnancy. Genome wide transcriptional 
changes data revealed differential expression of several E2 responsive genes following E2 
inhibition and replacement treatments. The results revealed importance of ER-mediated 
PI3K/Akt signaling essential for regulation of many transcriptional regulatory molecules 
in the CL and an interesting involvement of IGFBP5 as a link between E2 and IGF 
signaling. These findings further provide an insight into the role of IGFBP5 in E2-
mediated actions in rat CL during pregnancy. In conclusion, the present findings suggest 
inhibitory effect of IGFBP5 on E2-induced ERα function and hence, its selection as a 
target molecule for regulation of CL function and for many beneficial processes involved 
in anti-carcinogenic properties can be thought of. 
